Table 2.

Factors associated with presence of HCV viremia among 1,049 HCV-seropositive women (882 HIV-infected and 167 HIV-uninfected) at baseline WIHS visit, multivariate analysis^a

	Total no. of women	HCV-viremic (n, %)	OR (95% CI)b	p-Valuec
Age (years)
<35	248	190 (77%)	1.0
>35	801	662 (83%)	1.1 (0.8–1.7)	0.54
Race
White	187	145 (78%)	1.0
Hispanic	217	152 (70%)	0.8 (0.5–1.3)	0.37
Black	621	538 (87%)	1.9 (1.2–2.9)	0.005
Other	24	17 (71%)	0.6 (0.2–1.7)	0.39
History of cocaine use
No	785	622 (79%)
Yes	262	228 (87%)	1.3 (0.8–2.0)	0.29
History of crack/freebase cocaine use
No	714	556 (78%)	1.0
Yes	333	294 (88%)	1.6 (1.0–2.6)	0.04
History of marijuana/ hash use
No	760	608 (80%)
Yes	285	240 (84%)	1.1 (0.7–1.6)	0.71
Alcohol use
0/wk	474	372 (78%)
<3/wk	219	180 (82%)	1.1 (0.7–1.7)	0.65
3–13/wk	179	148 (83%)	0.9 (0.5–1.5)	0.67
13+/wk	147	127 (86%)	1.0 (0.6–1.8)	0.95
Current smoking
No	236	172 (73%)	1.0
Yes	811	678 (84%)	1.6 (1.1–2.4)	0.01
HBV status
Seronegative	135	113 (84%)	1.0
Anti-HBs only	23	20 (87%)	2.0 (0.4–9.5)	0.40
Anti-HBc(+)/anti-HBs(+)	341	260 (76%)	0.5 (0.3–0.9)	0.02
Anti-HBC(+) only	339	289 (85%)	0.8 (0.5–1.5)	0.58
HBsAg(+)	31	19 (61%)	0.2 (0.1–0.6)	0.002
HIV status
HIV(−)	167	129 (77%)
HIV(+)	882	723 (82%)	1.4 (0.9–2.2)	0.15

^aModel includes all variables with P < 0.20 on univariate analysis

^bOdds ratio (95% confidence interval) from dichotomous logistic regression

^cP-values < 0.05 are bolded